Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock
-
Number of holders
-
52
-
Total 13F shares, excl. options
-
19.7M
-
Shares change
-
-1.71M
-
Total reported value, excl. options
-
$19.7M
-
Value change
-
-$2.25M
-
Put/Call ratio
-
0.01
-
Number of buys
-
16
-
Number of sells
-
-25
-
Price
-
$1.00
Significant Holders of Kronos Bio, Inc. - Common Stock (KRON) as of Q3 2024
64 filings reported holding KRON - Kronos Bio, Inc. - Common Stock as of Q3 2024.
Kronos Bio, Inc. - Common Stock (KRON) has 52 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.7M shares
.
Largest 10 shareholders include Vida Ventures Advisors, LLC (2.77M shares), MILLENNIUM MANAGEMENT LLC (2.05M shares), VANGUARD GROUP INC (1.92M shares), PARTNERS CAPITAL INVESTMENT GROUP, LLP (1.61M shares), Alphabet Inc. (1.44M shares), ACADIAN ASSET MANAGEMENT LLC (1.3M shares), Wildcat Capital Management, LLC (1.3M shares), RENAISSANCE TECHNOLOGIES LLC (979K shares), Siren, L.L.C. (843K shares), and BlackRock, Inc. (802K shares).
This table shows the top 52 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.